113 related articles for article (PubMed ID: 22469521)
61. Treatment and outcome of newly diagnosed multiple myeloma patients > 75 years old: a retrospective analysis.
Al Saleh AS; Visram A; Parmar H; Muchtar E; Buadi FK; Dispenzieri A; Warsame R; Lacy MQ; Dingli D; Leung N; Go RS; Gonsalves WI; Kourelis TV; Hayman SR; Kapoor P; Gertz MA; Kyle RA; Rajkumar SV; Kumar SK
Leuk Lymphoma; 2021 Dec; 62(12):3011-3018. PubMed ID: 34263694
[TBL] [Abstract][Full Text] [Related]
62. Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group.
Katodritou E; Kastritis E; Gatt M; Cohen YC; Avivi I; Pouli A; Lalayianni C; Lavi N; Delimpasis S; Kyrtsonis MC; Michael M; Suriu C; Miri Z; Tzafarti K; Vadikoliou C; Maltezas D; Zikos P; Ganzel C; Vaxman Y; Aviv A; Christoforidou A; Gavriatopoulou M; Shaulov A; Verrou E; Papanota AM; Fakinos G; Gkioka AI; Palaska V; Triantafyllou T; Konstantinidou P; Anagnostopoulos A; Terpos E; Dimopoulos MA
Am J Hematol; 2020 May; 95(5):465-471. PubMed ID: 32048329
[TBL] [Abstract][Full Text] [Related]
63. Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma.
Riccardi A; Mora O; Brugnatelli S; Tinelli C; Spanedda R; De Paoli A; Barbarano L; Di Stasi M; Bergonzi C; Giordano M; Delfini C; Nicoletti G; Rinaldi E; Piccinini L; Valentini D; Ascari E
Br J Cancer; 1998; 77(3):485-91. PubMed ID: 9472648
[TBL] [Abstract][Full Text] [Related]
64. Multiple myeloma: presenting features and survival according to hospital referral. Eastern Cooperative Study Group on Monoclonal Gammopathies.
Patriarca F; Fanin R; Silvestri F; Russo D; Baccarani M
Leuk Lymphoma; 1998 Aug; 30(5-6):551-62. PubMed ID: 9711917
[TBL] [Abstract][Full Text] [Related]
65. Early mortality in elderly patients undergoing treatment for multiple myeloma in real-world practice.
Xia J; Wang L; Zhou X; Wang J; Wang H; Guo H
J Int Med Res; 2018 Jun; 46(6):2230-2237. PubMed ID: 29584537
[TBL] [Abstract][Full Text] [Related]
66. Effect of novel agents on the risk of early death of newly diagnosed symptomatic multiple myeloma patients: A single Centre retrospective analysis.
Galli M; Paris L; Pavoni C; Delaini F; Rambaldi A
Am J Hematol; 2019 Jan; 94(1):E11-E13. PubMed ID: 30328638
[No Abstract] [Full Text] [Related]
67. The albumin and monoclonal protein ratio as prognostic marker for multiple myeloma in the era of novel agents.
Kádár K; Wolf K; Tábori J; Karádi I; Várkonyi J
Pathol Oncol Res; 2012 Jul; 18(3):557-61. PubMed ID: 22314327
[TBL] [Abstract][Full Text] [Related]
68. Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma.
Hsu P; Lin TW; Gau JP; Yu YB; Hsiao LT; Tzeng CH; Chen PM; Chiou TJ; Liu JH; Liu YC; Liu CJ
Medicine (Baltimore); 2015 Dec; 94(50):e2305. PubMed ID: 26683968
[TBL] [Abstract][Full Text] [Related]
69. Treatment of multiple myeloma in Akita: features and outcomes in the era of novel agents.
Shida S; Takahashi N; Niioka T; Kitabayashi A; Kawabata Y; Kume M; Saitoh H; Hatano Y; Ichikawa Y; Kuroki J; Motegi M; Kobayashi T; Kameoka Y; Tagawa H; Fujishima N; Yoshioka T; Hirokawa M; Miura M; Sawada K
J Clin Exp Hematop; 2014; 54(1):89-93. PubMed ID: 24942951
[No Abstract] [Full Text] [Related]
70. Safe and successful teclistamab treatment in very elderly multiple myeloma (MM) patients: a case report and experience from a total of three octogenarians.
Dieterle MP; Mostufi-Zadeh-Haghighi G; Kus JW; Wippel C; Brugger Z; Miething C; Wäsch R; Engelhardt M
Ann Hematol; 2023 Dec; 102(12):3639-3641. PubMed ID: 37710140
[No Abstract] [Full Text] [Related]
71. Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study.
Howell D; Smith A; Appleton S; Bagguley T; Macleod U; Cook G; Patmore R; Roman E
Br J Haematol; 2017 Apr; 177(1):67-71. PubMed ID: 28146275
[TBL] [Abstract][Full Text] [Related]
72. [Clinical benefit and regimen selection for patients with newly-diagnosed multiple myeloma in the era of novel agents].
Geng CY; Chen WM
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):297-8. PubMed ID: 23668199
[No Abstract] [Full Text] [Related]
73. Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study.
Brink M; Groen K; Sonneveld P; Minnema MC; Broijl A; Dinmohamed AG; van der Spek E; Levin MD; Ypma PF; de Waal E; Posthuma EFMW; Zweegman S; van de Donk NWCJ
Blood Cancer J; 2021 Nov; 11(11):178. PubMed ID: 34764237
[TBL] [Abstract][Full Text] [Related]
74. Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysis.
Britto J; Seow H; Pond GR; Wildes TM; McCurdy A; Visram A; Ebraheem M; Aljama M; Gayowsky A; Mian H
J Geriatr Oncol; 2023 Nov; 14(8):101592. PubMed ID: 37479538
[No Abstract] [Full Text] [Related]
75. Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score.
D'Agostino M; Larocca A; Offidani M; Liberati AM; Gaidano G; Petrucci MT; Derudas D; Capra A; Zambello R; Cascavilla N; de Fabritiis P; Innao V; Bonello F; Patriarca F; Benevolo G; Giuliani N; Aitoro G; Guglielmelli T; Di Raimondo F; Corradini P; Musto P; Hájek R; Sonneveld P; Boccadoro M; Bringhen S
Blood Cancer J; 2021 Apr; 11(4):73. PubMed ID: 33846296
[No Abstract] [Full Text] [Related]
76. Multiple myeloma: the (r)evolution of current therapy and a glance into future.
Gulla A; Anderson KC
Haematologica; 2020 Oct; 105(10):2358-2367. PubMed ID: 33054076
[TBL] [Abstract][Full Text] [Related]
77. Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role.
Rodríguez-Otero P; Mateos MV; Martínez-López J; Martín-Calvo N; Hernández MT; Ocio EM; Rosiñol L; Martínez R; Teruel AI; Gutiérrez NC; Bargay J; Bengoechea E; González Y; de Oteyza JP; Gironella M; Encinas C; Martín J; Cabrera C; Palomera L; de Arriba F; Cedena MT; Paiva B; Puig N; Oriol A; Bladé J; Lahuerta JJ; San Miguel JF
Leukemia; 2018 Nov; 32(11):2427-2434. PubMed ID: 29515235
[TBL] [Abstract][Full Text] [Related]
78. Managing myeloma with limited resources in the era of novel drugs.
Dimopoulos MA; Kastritis E
Leuk Lymphoma; 2018 Oct; 59(10):2269-2270. PubMed ID: 29966456
[No Abstract] [Full Text] [Related]
79. Personalized Treatment of Multiple Myeloma in Frail Patients.
Lipof JJ; Abdallah N; Lipe B
Curr Oncol Rep; 2024 May; ():. PubMed ID: 38761302
[TBL] [Abstract][Full Text] [Related]
80. A real-world data analysis of predictors of early mortality after a diagnosis of multiple myeloma.
Grant SJ; Wildes TM; Rosko AE; Silberstein J; Giri S
Cancer; 2023 Jul; 129(13):2023-2034. PubMed ID: 36989073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
